Fixed dose pharmaceutical composition of valsartan and sacubitril
US11819577B2 · kind B2 · utility
0Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2022 |
| Grant date | Nov 21, 2023 |
| Priority date | — |
| Expiry date | Jun 7, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This present invention relates to pharmaceutical composition comprising fixed dose combination of valsartan or pharmaceutically acceptable salts thereof and sacubitril or pharmaceutically acceptable salts thereof. Further this invention also relates to process for the preparation of said composition and use of the said composition in treatment of certain diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.